• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FERRING PHARM. INC. EUFLEXXA SODIUM HYALURONATE; EUFLEXXA SODIUM HYALURONATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FERRING PHARM. INC. EUFLEXXA SODIUM HYALURONATE; EUFLEXXA SODIUM HYALURONATE Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problems Fever (1858); Headache (1880); Hypersensitivity/Allergic reaction (1907); Itching Sensation (1943); Muscular Rigidity (1968); Pain (1994); Rash (2033); Urticaria (2278); Sore Throat (2396)
Event Date 06/25/2013
Event Type  Injury  
Event Description
A few days after receiving euflexxa injections to bilateral knees, i noticed itching in both ears and on both elbows.The skin on my elbows became psoriasis in nature.On (b)(6) 2013 11:00 am i received the 2nd injection of the euflexxa series in bilateral knees by my orthopedic doctor.At approx.12:30 i began to have generalized itching.I took a benadryl (generic) 25mg.Itching continued to increase.At approx.5 pm i noticed a blotchy rash on my upper arms, abdomen, back and thighs.That evening the rash began to appear more as red raised hives.My fingertips became very tender as if rubbed on a rough surface and my hands became sensitive to warm water.Joints on my left hand became stiff and sore with movement.The pain began to increase and became severe in almost all of my joints.It radiated from joint to joint becoming so severe in my hand and wrist that i thought i might need to go to the emergency room, but i didn't want to move because the pain was so excruciating.I developed a severe sore throat, had a headache and low grade fever.No redness was ever noted at the injection sites.That radiating joint pain continued over the next several days although not as severe.I saw the orthopedic doctor on (b)(6) 2013 was given a medrol dose pack and refused any final injections in the euflexxa series.He prescribed a medrol dose pack, which i filled and took until finished.I saw my pmd on (b)(6) 2013 instructed to take an antihistamine which i was already taking and pepcid.I had labs drawn on this day also.I was also advised to see an allergist which i saw on (b)(6) 2013 since i continued with itching and rash.I was given triamcinolone cream 0.1% and told to take claritin and pepcid everyday, which i started taking.I needed to take the claritin and pepcid to the end of (b)(6).When i tried to stop it, the itching returned, mostly noted in eyes, face and ears.During this entire episode i had to use special shampoo due to the itching and i also became sensitive to several foods with itching and rash increasing.Now that has subsided.I never had any allergies prior to this.Needed md follow up and also had to see allergist.Strength: questionably 1 cc each syringe.Quantity: 1 injection each knee.Date the person first started taking or using the product: on (b)(6) 2013.Date the person stopped taking or using the product: on (b)(6) 2013.Why was the person using the product: osteoarthritis bilateral knees.I was giving synvisc rt knee in 2011.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA SODIUM HYALURONATE
Type of Device
EUFLEXXA SODIUM HYALURONATE
Manufacturer (Section D)
FERRING PHARM. INC.
MDR Report Key3727725
MDR Text Key4328177
Report NumberMW5035454
Device Sequence Number1
Product Code MOZ
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 03/26/2014
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received04/01/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Other Device ID Number1ST DOSE G16436A 2ND DOSE G164
Was Device Available for Evaluation? No
Patient Sequence Number1
Treatment
METOPROLOL; LEVOTHVROXINE
Patient Outcome(s) Other;
Patient Age61 YR
Patient Weight98
-
-